ANDA 86833, held by Actavis Mid Atlantic. Cyproheptadine Hydrochloride.
As of Nov 16, 2026, ANDA 86833 (Cyproheptadine Hydrochloride), held by Actavis Mid Atlantic, was first approved by FDA on Apr 16, 1980, with 14 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 16, 1980 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyproheptadine Hydrochloride2MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** ยท syrup;oral | Cyproheptadine Hydrochloride | DiscontinuedReference drug |
| Oct 2, 2000 | Supplement 27Manufacturing | Approved | None posted |
| Sep 29, 1997 | Supplement 25Labeling | Approved | None posted |
| Sep 28, 1990 | Supplement 24Manufacturing | Approved | None posted |
| Apr 5, 1990 | Supplement 22Labeling | Approved | None posted |
| Dec 26, 1989 | Supplement 21Labeling | Approved | None posted |
| Nov 6, 1989 | Supplement 16Labeling | Approved | None posted |
| Oct 11, 1989 | Supplement 20Labeling | Approved | None posted |
| Mar 3, 1989 | Supplement 19Manufacturing | Approved | None posted |
| Mar 3, 1989 | Supplement 18Manufacturing | Approved | None posted |
| Mar 3, 1989 | Supplement 17Manufacturing | Approved | None posted |
| Nov 5, 1986 | Supplement 15Manufacturing | Approved | None posted |
| Apr 11, 1983 | Supplement 12Manufacturing | Approved | None posted |
| Nov 26, 1982 | Supplement 11Manufacturing | Approved | None posted |
| Nov 22, 1982 | Supplement 10Manufacturing | Approved | None posted |
| Apr 16, 1980 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters